v3.25.2
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS’ EQUITY (DEFICIT) - USD ($)
Ordinary Shares
Additional Paid-in Capital
Retained earnings (Accumulated Deficit)
Total
Balance at Mar. 31, 2024 $ 144 $ 24,856 $ (6,748) $ 18,252
Balance (in Shares) at Mar. 31, 2024 1,437,500      
Net income (loss)     (30,000) (30,000)
Balance at Jun. 30, 2024 $ 144 24,856 (36,748) (11,748)
Balance (in Shares) at Jun. 30, 2024 1,437,500      
Balance at Mar. 31, 2025 $ 144 24,856 (163,268) $ (138,268)
Balance (in Shares) at Mar. 31, 2025 1,437,500     1,908,348
Proceeds allocated to Public Rights $ 0 5,387,388 0 $ 5,387,388
Sale of private placement shares $ 24 2,408,456 0 2,408,480
Sale of private placement shares (in Shares) 240,848      
Issuance of representative shares $ 23 2,112,577 0 2,112,600
Issuance of representative shares (in Shares) 230,000      
Underwriters’ discount and other offering expenses $ 0 (3,264,646) 0 (3,264,646)
Accretion of ordinary share subject to redemption value 0 (1,970,381) 0 (1,970,381)
Net income (loss) 0 0 332,078 332,078
Balance at Jun. 30, 2025 $ 191 $ 4,698,250 $ 168,810 $ 4,867,251
Balance (in Shares) at Jun. 30, 2025 1,908,348     1,437,500